In addition, SCO treatment significantly decreased Ach levels and expression of ChAT protein while increasing AChE activity in both the hippocampus and cortex, suggesting that the observed cognitive impairments were induced by cholinergic dysfunction. The gene discussed is ACHE; the disease is Cognitive impairment.